Style
Deep ValueTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Pharvaris N V(PHVS) | 4,643,430 | $160.6M | 30.92% |
| 2 | Parabilis Medicines Inc(PBLS) | 5,266,697 | $144.1M | 27.75% |
| 3 | Alumis Inc(ALMS) | 4,528,408 | $127.4M | 24.53% |
| 4 | Achieve Life Science Inc(ACHV) | 5,914,720 | $38.6M | 7.44% |
| 5 | ALX Oncology Hldgs Inc(ALXO) | 12,884,638 | $26.7M | 5.14% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 53.29% | 41.33% | -11.96% |
| Unclassified | 46.71% | 58.67% | +11.96% |
Quarter-over-quarter weight changes by market cap
| Harmony Biosciences Hldgs in(HRMY) |
| 472,194 |
| $17.2M |
| 3.31% |
| 7 | Lyell Immunopharma Inc(LYEL) | 337,697 | $4.7M | 0.91% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Unclassified | 46.71% | 58.67% | +11.96% |
| Mid Cap | 35.56% | 24.53% | -11.03% |
| Micro Cap | 10.43% | 12.57% | +2.14% |
| Small Cap | 7.3% | 4.22% | -3.08% |
Quarter-over-quarter position changes